Training the next generation of pharmacometric modelers: a multisector perspective
- PMID: 37573528
- DOI: 10.1007/s10928-023-09878-4
Training the next generation of pharmacometric modelers: a multisector perspective
Erratum in
-
Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.J Pharmacokinet Pharmacodyn. 2024 Feb;51(1):89. doi: 10.1007/s10928-023-09885-5. J Pharmacokinet Pharmacodyn. 2024. PMID: 37670078 No abstract available.
Abstract
The current demand for pharmacometricians outmatches the supply provided by academic institutions and considerable investments are made to develop the competencies of these scientists on-the-job. Even with the observed increase in academic programs related to pharmacometrics, this need is unlikely to change in the foreseeable future, as the demand and scope of pharmacometrics applications keep expanding. Further, the field of pharmacometrics is changing. The field largely started when Lewis Sheiner and Stuart Beal published their seminal papers on population pharmacokinetics in the late 1970's and early 1980's and has continued to grow in impact and use since its inception. Physiological-based pharmacokinetics and systems pharmacology have grown rapidly in scope and impact in the last decade and machine learning is just on the horizon. While all these methodologies are categorized as pharmacometrics, no one person can be an expert in everything. So how do you train future pharmacometricians? Leading experts in academia, industry, contract research organizations, clinical medicine, and regulatory gave their opinions on how to best train future pharmacometricians. Their opinions were collected and synthesized to create some general recommendations.
Keywords: Education; Modeling and simulation; Pharmacometrics.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843. JBI Database System Rev Implement Rep. 2016. PMID: 27532314
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17. J Psychiatr Ment Health Nurs. 2024. PMID: 38230967
-
"Living Independently Means Everything to Me": The Voice of Australian Autistic Adults.Autism Adulthood. 2024 Sep 16;6(3):312-320. doi: 10.1089/aut.2022.0102. eCollection 2024 Sep. Autism Adulthood. 2024. PMID: 39371361
Cited by
-
The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases.Pharmaceutics. 2024 Dec 5;16(12):1559. doi: 10.3390/pharmaceutics16121559. Pharmaceutics. 2024. PMID: 39771538 Free PMC article. Review.
-
Preclinical Data Extrapolation to Clinical Reality: A Translational Approach.Curr Drug Discov Technol. 2025;22(3):e250424229318. doi: 10.2174/0115701638302778240417045451. Curr Drug Discov Technol. 2025. PMID: 38676496 Review.
-
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare.Pharmaceutics. 2024 Feb 27;16(3):332. doi: 10.3390/pharmaceutics16030332. Pharmaceutics. 2024. PMID: 38543226 Free PMC article. Review.
-
A physiologically-based quantitative systems pharmacology model for mechanistic understanding of the response to alogliptin and its application in patients with renal impairment.J Pharmacokinet Pharmacodyn. 2025 Jan 16;52(1):13. doi: 10.1007/s10928-025-09961-y. J Pharmacokinet Pharmacodyn. 2025. PMID: 39821812
References
-
- Benet LZ, Rowland M (1982) Pharmacometrics: a new journal section. J Pharmacokinetic Pharmacodynam 10:349–350 - DOI
-
- Michelet R, Aulin LBS, Borghardt JM, Dalla Costa T, Denti P, Ibarra M, Ma G, Meibohm B, Pillai GC, Schmidt S, Hennig S, Kloft C (2023) Barriers to global pharmacometrics: educational challenges and opportunities across the globe. CPT: Pharmacometrics Syst Pharmacol 12:743–747 - PubMed
-
- Gieschke R, Steimer JL (2000) Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development. Eur J Drug Metab Pharmacokin 25:49–58 - DOI
-
- Lee WH, Fujiwara M (1971) Pharmacometrics of guinea-pig’s gallbladder in vitro. Taiwan Yi Xue Hui Za Zhi 70:687–696 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources